JW (Cayman) Therapeutics Co. Ltd

Research JW (Cayman) Therapeutics Co. Ltd (JNY) on Bullrun: market cap EUR 69.13M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerJNY
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 69.13M
• Financial periodFY2025
• RevenueEUR 283.65M
• Revenue growth79.3%
• Net income-EUR 555.29M
• Free cash flow-EUR 78.46M
• Gross margin61.0%

Valuation Snapshot

latest market cap is EUR 69.13M.

About JW (Cayman) Therapeutics Co. Ltd

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People's Republic of China. The company offers cell-based immunotherapies, including CAR-T treatment, a treatment method that uses human immune cells to fight cancer.

Frequently asked questions

What is JW (Cayman) Therapeutics Co. Ltd's market cap?

JW (Cayman) Therapeutics Co. Ltd's market capitalization is EUR 69.13M.

What does JW (Cayman) Therapeutics Co. Ltd do?

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People's Republic of China.